- Pfizer Inc., headquartered in New York, New York, is a leading global biopharmaceutical company known for its innovative medicines and vaccines, particularly in oncology and infectious diseases.
- In 2026, Pfizer is set to present over 40 oncology studies at the ASCO Annual Meeting, showcasing advancements in its cancer pipeline, including updates on LORBRENA® and BRAFTOVI® for specific cancer types.
- Key partnerships include collaborations for vaccine development, such as the recent announcement of a Lyme disease vaccine candidate demonstrating strong efficacy in Phase 3 trials with Valneva.
- Pfizer's ideal buyers are healthcare providers and institutions seeking cutting-edge treatments and vaccines, especially as the company navigates declining COVID-related sales and focuses on expanding its oncology portfolio.
Pfizer's workforce is organized across 19 departments, with Operations leading in headcount at 6,828 employees, followed by Information Technology with 4,296 and the Executive department at 4,172. This distribution highlights a strong emphasis on operational efficiency and technological support, crucial for a pharmaceutical company. The presence of Community and Social Services, with 4,012 employees, indicates a commitment to societal impact alongside core business functions.
Pfizer operates in 1,267 locations, with a significant concentration in New York, NY, housing 8,065 employees. Other notable locations include Collegeville, PA, with 601 employees, and Kalamazoo, MI, with 486. The large 'Other' category, comprising 27,294 employees, suggests a distributed workforce across various sites, reflecting a strategic approach to geographic diversity while maintaining a strong presence in key urban centers.
